Advances in Antibody-Drug Conjugates (ADCs): Targeted Cancer Therapy
Introduction Antibody-drug conjugates (ADCs) represent a promising new class of biopharmaceuticals that combine the specificity of monoclonal antibodies with the potent killing ability of cytotoxic drugs. Designed to deliver targeted cancer therapy, ADCs aim to improve the effectiveness of cancer treatments while minimizing damage to healthy cells. This article will explore how ADCs work, the … Read more